Detection of cardiovascular risk factors in patients with psychosis

被引：2

作者：

Vinas, Lydia ^{[2
]}

Fernandez, Maribel ^{[3
]}

San Emeterio, Luisa ^{[4
]}

Martin-Lopez, Luis M. ^{[1
]}

机构：

[1] INAD, Linea Primaria Salut Mental, Barcelona, Spain

[2] SAP Litoral Inst Catalan Salud ICS, Equipo Atenc Primaria Pueblo Nuevo, Barcelona, Spain

[3] SAP Litoral Inst Catalan Salud ICS, Serv Atenc Primaria Litoral Barcelona, Barcelona, Spain

[4] Linea Primaria INAD, Ctr Salud Mental St Martin Norte, Barcelona, Spain

来源：

ATENCION PRIMARIA | 2011年 / 43卷 / 07期

关键词：

METABOLIC SYNDROME; SCHIZOPHRENIA; ANTIPSYCHOTICS; OUTPATIENTS;

D O I：

10.1016/j.aprim.2010.04.021

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：386 / 387

页数：2

共 6 条

[1] A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study
Arango, Celso
Bobes, Julio
Aranda, Pedro
Carmena, Rafael
Garcia-Garcia, Margarida
Rejas, Javier
[J]. SCHIZOPHRENIA RESEARCH, 2008, 104 (1-3) : 1 - 12
[2] A UK audit of screening for the metabolic side effects of antipsychotics in community patients
Barnes, Thomas R. E.
Paton, Carol
Cavanagh, Mary-Rose
Hancock, Elizabeth
Taylor, David M.
[J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (06) : 1397 - 1403
[3] Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia
Barnett, A. H.
Mackin, P.
Chaudhury, I.
Farooqi, A.
Gadsby, R.
Heald, A.
Hill, J.
Millar, H.
Peveler, R.
Rees, A.
Singh, V.
Taylor, D.
Vora, J.
Jones, P. B.
[J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2007, 21 (04) : 357 - 373
[4] Coca Diaz M M, 2005, Aten Primaria, V35, P436, DOI 10.1157/13074802
[5] Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: A controlled study
Jennex, Amber
Gardner, David M.
[J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2008, 53 (01): : 34 - 42
[6] Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial and comparison with national estimates from NHANES III
McEvoy, JP
Meyer, JM
Goff, DC
Nasrallah, HA
Davis, SA
Sullivan, L
Meltzer, HY
Hsiao, J
Stroup, TS
Lieberman, JA
[J]. SCHIZOPHRENIA RESEARCH, 2005, 80 (01) : 19 - 32

← 1 →